HIGHLIGHTS
- who: Karam Khaddour from the The State University of New Jersey, United States have published the article: Case report: Real-world experience using a personalized cancer-specific circulating tumor DNA assay in different metastatic melanoma scenarios, in the Journal: (JOURNAL)
- what: Our case series highlights the potential clinical utility and limitations of using patient-informed, tumor-specific ctDNA assay for clinical decision-making in the treatment of metastatic melanoma patients in the real-world setting.
- how: Sequencing results were analyzed using Natera`s proprietary tissue variant calling pipeline and 16 highly ranked tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.